BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 17419570)

  • 1. [Brachytherapy of prostate cancers].
    de Crevoisier R
    Soins; 2007 Mar; (713):41-2. PubMed ID: 17419570
    [No Abstract]   [Full Text] [Related]  

  • 2. Power against prostate cancer. Intensity-modulated radiation therapy and interstitial brachytherapy.
    Cash JC
    Adv Nurse Pract; 2006 Sep; 14(9):37-42. PubMed ID: 16972442
    [No Abstract]   [Full Text] [Related]  

  • 3. Factors affecting patient selection for prostate brachytherapy: what nurses should know.
    Zeroski D; Abel L; Butler WM; Wallner K; Merrick GS
    Clin J Oncol Nurs; 2005 Oct; 9(5):553-60. PubMed ID: 16235582
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of urinary assessment scores in the nursing management of patients receiving prostate brachytherapy.
    Abel LJ; Blatt HJ; Stipetich RL; Fuscardo JA; Dafoe-Lambie JC; Dorsey AT; Butler WM; Merrick GS
    Clin J Oncol Nurs; 2000; 4(3):126-9. PubMed ID: 11235250
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Preimplant predictive factors of urinary retention after iodine 125 prostate brachytherapy.
    Mabjeesh NJ; Chen J; Stenger A; Matzkin H
    Urology; 2007 Sep; 70(3):548-53. PubMed ID: 17905113
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Brachytherapy: a minimally invasive option for treating prostate cancer.
    Stahlinski CR; Friedman FP; Finklestein S
    Minim Invasive Surg Nurs; 1994; 8(3):106-9. PubMed ID: 7812389
    [No Abstract]   [Full Text] [Related]  

  • 7. State-of-the-art: prostate LDR brachytherapy.
    Voulgaris S; Nobes JP; Laing RW; Langley SE
    Prostate Cancer Prostatic Dis; 2008; 11(3):237-40. PubMed ID: 18364676
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Conformal radiotherapy of prostate cancers].
    de Crevoisier R
    Soins; 2007 Mar; (713):40-1. PubMed ID: 17419569
    [No Abstract]   [Full Text] [Related]  

  • 9. [Brachytherapy for localised prostate cancer].
    Peiffert D
    Cancer Radiother; 2007 Nov; 11(6-7):373-8. PubMed ID: 17962060
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Androgen deprivation-mediated cytoreduction before interstitial brachytherapy for prostate cancer does not abrogate the elevated risk of urinary morbidity associated with larger initial prostate volume.
    Petit JH; Gluck C; Kiger WS; Laury Henry D; Karasiewicz C; Talcott JA; Berg S; Holupka EJ; Kaplan ID
    Brachytherapy; 2007; 6(4):267-71. PubMed ID: 17959423
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Predictive factors for acute and late urinary toxicity after permanent prostate brachytherapy: long-term outcome in 712 consecutive patients.
    Keyes M; Miller S; Moravan V; Pickles T; McKenzie M; Pai H; Liu M; Kwan W; Agranovich A; Spadinger I; Lapointe V; Halperin R; Morris WJ
    Int J Radiat Oncol Biol Phys; 2009 Mar; 73(4):1023-32. PubMed ID: 19111402
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prostate radiotherapy is associated with second cancers in many organs, not just the colorectum.
    Brenner DJ; Hall EJ; Curtis RE; Ron E
    Gastroenterology; 2005 Aug; 129(2):773-4; author reply 774-5. PubMed ID: 16083746
    [No Abstract]   [Full Text] [Related]  

  • 13. Prostate cancer treatment with radioactive seed implantation.
    Davis DL
    AORN J; 1998 Jul; 68(1):18, 21-3, 26-30 passim; quiz 42, 45. PubMed ID: 9675408
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Education and nursing care of brachytherapy patients.
    Dunne-Daly CF
    Cancer Nurs; 1994 Oct; 17(5):434-44. PubMed ID: 7954392
    [No Abstract]   [Full Text] [Related]  

  • 15. Long-term urinary sequelae following 125iodine prostate brachytherapy.
    Crook J; Fleshner N; Roberts C; Pond G
    J Urol; 2008 Jan; 179(1):141-5; discussion 146. PubMed ID: 17997424
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Role of brachytherapy for radical treatment of prostate cancer].
    Pan'shin GA; Kaprin AD; Al'bitskiĭ IA; Milenin KN; Khmelevskiĭ EV
    Vopr Onkol; 2006; 52(6):663-9. PubMed ID: 17338245
    [No Abstract]   [Full Text] [Related]  

  • 17. The nature and extent of urinary morbidity in relation to prostate brachytherapy urethral dosimetry.
    Neill M; Studer G; Le L; McLean M; Yeung I; Pond G; Crook JM
    Brachytherapy; 2007; 6(3):173-9. PubMed ID: 17681239
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Nurse's role in the patient care].
    Beguin AM
    Soins; 2007 Mar; (713):47. PubMed ID: 17419573
    [No Abstract]   [Full Text] [Related]  

  • 19. Urinary side effects and complications after permanent prostate brachytherapy: the MD Anderson Cancer Center experience.
    Anderson JF; Swanson DA; Levy LB; Kuban DA; Lee AK; Kudchadker R; Phan J; Bruno T; Frank SJ
    Urology; 2009 Sep; 74(3):601-5. PubMed ID: 19589580
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Seed implant brachytherapy for prostate cancer.
    Halperin R
    CMAJ; 2001 Oct; 165(8):1003; author reply 1004. PubMed ID: 11699690
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.